We are live on ! Find out more
BAMCO Inc

BAMCO Inc Portfolio holdings

AUM $66.6B
1-Year Est. Return 7.35%
This Fund
S&P 500
This Quarter Est. Return
+7.81%
1 Year Est. Return
+7.35%
3 Year Est. Return
+62.2%
5 Year Est. Return
+84.27%
10 Year Est. Return
+776.55%
AUM
$37.7B
AUM Growth
+$825M
Cap. Flow
-$555M
Cap. Flow %
-1.47%
Top 10 Hldgs %
42.45%
Holding
343
New
37
Increased
135
Reduced
115
Closed
13

Top Buys

Rank Stock Value
1
IT icon
Gartner
IT
+$195M
2
MSCI icon
MSCI
MSCI
+$127M
3
BIRK icon
Birkenstock
BIRK
+$91.8M
4
LOAR icon
Loar Holdings
LOAR
+$84.7M
5
AAON icon
Aaon
AAON
+$59.5M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$372M
2
IRDM icon
Iridium Communications
IRDM
+$190M
3
FDS icon
Factset
FDS
+$158M
4
GTLS
Chart Industries
GTLS
+$146M
5
KTOS icon
Kratos Defense & Security Solutions
KTOS
+$138M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 30.84%
2 Financials 20.19%
3 Technology 18.62%
4 Real Estate 8.92%
5 Healthcare 8.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TEVA icon
276
Teva Pharmaceuticals
TEVA
$42.5B
$2.22M 0.01%
110,000
+10,000
+10% +$176K
FRPT icon
277
Freshpet
FRPT
$3.4B
$2.13M 0.01%
38,628
+52
+0.1% +$3.22K
LITE icon
278
Lumentum
LITE
$80.3B
$2.05M 0.01%
+12,582
New +$1.57M
COHR icon
279
Coherent
COHR
$54.7B
$2.05M 0.01%
18,994
+9,792
+106% +$976K
VRTX icon
280
Vertex Pharmaceuticals
VRTX
$137B
$2.04M 0.01%
5,200
-3,800
-42% -$1.59M
DOCS icon
281
Doximity
DOCS
$4.76B
$1.98M 0.01%
27,000
+12,000
+80% +$782K
RHI icon
282
Robert Half
RHI
$4.64B
$1.96M 0.01%
57,600
– –
LRCX icon
283
Lam Research
LRCX
$378B
$1.81M ﹤0.01%
13,529
-1,039
-7% -$110K
PODD icon
284
Insulet
PODD
$10.1B
$1.76M ﹤0.01%
5,700
– –
CDTX
285
DELISTED
Cidara Therapeutics
CDTX
$1.68M ﹤0.01%
+17,500
New +$1.12M
ARE icon
286
Alexandria Real Estate Equities
ARE
$8.87B
$1.68M ﹤0.01%
20,104
-135,902
-87% -$10.9M
IONS icon
287
Ionis Pharmaceuticals
IONS
$10.1B
$1.64M ﹤0.01%
+25,000
New +$1.22M
PGR icon
288
Progressive
PGR
$127B
$1.63M ﹤0.01%
6,600
-1,400
-18% -$345K
ALNY icon
289
Alnylam Pharmaceuticals
ALNY
$31.7B
$1.6M ﹤0.01%
+3,500
New +$1.43M
ROIV icon
290
Roivant Sciences
ROIV
$25.1B
$1.59M ﹤0.01%
+105,000
New +$1.3M
UNH icon
291
UnitedHealth
UNH
$353B
$1.48M ﹤0.01%
+4,300
New +$1.3M
MANU icon
292
Manchester United
MANU
$3.81B
$1.37M ﹤0.01%
90,448
– –
CYTK icon
293
Cytokinetics
CYTK
$10B
$1.35M ﹤0.01%
+24,500
New +$1.01M
CFLT
294
DELISTED
Confluent
CFLT
$1.29M ﹤0.01%
65,000
-100,000
-61% -$2.09M
BLK icon
295
Blackrock
BLK
$180B
$1.28M ﹤0.01%
1,100
– –
XENE icon
296
Xenon Pharmaceuticals
XENE
$5.81B
$1.2M ﹤0.01%
30,000
-26,000
-46% -$916K
MDGL icon
297
Madrigal Pharmaceuticals
MDGL
$12.3B
$1.19M ﹤0.01%
+2,600
New +$970K
NVO
298
Novo Nordisk
NVO
$202B
$1.19M ﹤0.01%
21,441
– –
ABVX
299
Abivax
ABVX
$9.89B
$1.19M ﹤0.01%
+14,000
New +$858K
ASND icon
300
Ascendis Pharma A/S
ASND
$16.3B
$1.11M ﹤0.01%
+5,600
New +$1.04M
10 11
12
13 14

Similar funds

NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Bank of Nova Scotia
Bank of Nova Scotia Toronto, Ontario, Canada $66.2B AUM 46.3% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $65.5B AUM 24.25% 1-Year Est. Return
Universal-Beteiligungs- und Servicegesellschaft
Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return
Aviva
Aviva London, United Kingdom $67.9B AUM 39.2% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $65.2B AUM 31.44% 1-Year Est. Return

BAMCO Inc's Q3 2025 Portfolio in Review

As of Q3 2025, BAMCO Inc held 343 positions worth $37.7B, up 2.2% from $36.9B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

BAMCO Inc's Q3 2025 filing shows 37 new, 135 increased, 115 reduced and 13 closed positions. Its largest new stake was Aaon: 726,907 shares worth $67.9M. The largest sale was Tesla, an estimated $372M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 31% of assets, up from 28% a quarter earlier, followed by Financials and Technology.

  • BAMCO Inc's largest Q3 2025 buy was Aaon: 726,907 shares worth $67.9M.
  • BAMCO Inc added most to Gartner in Q3 2025, an estimated $195M increase.
  • BAMCO Inc's biggest Q3 2025 reduction was Tesla, cutting an estimated $372M.
  • BAMCO Inc fully exited Chart Industries in Q3 2025, selling an estimated $146M.
  • BAMCO Inc's ten largest holdings make up 42% of its $37.7B portfolio in Q3 2025.
  • BAMCO Inc opened 37 new positions and closed 13 in Q3 2025.
  • BAMCO Inc's portfolio value rose 2.2% quarter-over-quarter to $37.7B.

Based on BAMCO Inc's 13F filing for Q3 2025, filed 14 Nov 2025.